Trials / Completed
CompletedNCT04018456
Regenerative Endodontic Treatment of Mature Necrotic Teeth With Apical Periodontitis
Regenerative Root Canal Treatment of Mature Teeth With Pulp Necrosis and Apical Periodontitis Using Biodentine Compared With MTA: Randomized Clinical Double-blind Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 10 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this prospective, randomized, controlled double-blind study is to evaluate the effectiveness of biodentine compared with MTA used as pulp space barrier on discoloration of teeth after regenerative based non-obturation root canal treatment in mature single canal with pulp necrosis and apical periodontitis.
Detailed description
• Regenerative endodontic treatment will be performed through two visits: First visit aims to clean and disinfect the tooth canal by copious irrigation with NaOCL and EDTA solution . At the end of first visit, canal will be dressed by CaOH as intracanal medicaments. Second visit will be after two weeks. After removal of CaOH dressing by copius irrigation, evoking bleeding inside canal by over instrumentation. When blood become semi-coagulated, according to the random sequence number of the participants, either biodentine or white MTA will be placed as pulp space barrier. At the end of treatment, the access cavity will be sealed with composite restoration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Biodentine | Biodentine is calcium silicate based cement which is bioactive and inductive material. Biodentine will be applied as coronal plug material. |
| OTHER | White MTA | MTA is calcium silicate based cement which is bioactive and inductive material. MTA is used in most cases of regenerative endodontics and it will be applied as coronal plug material. |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2022-01-01
- Completion
- 2023-06-01
- First posted
- 2019-07-12
- Last updated
- 2024-01-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04018456. Inclusion in this directory is not an endorsement.